rpsA Resolved · high auto-curated

H37Rv Rv1630 · MTBC0 mtbc0_001738 · 481 aa · 1845506–1846951 MTBC0 (+) · RefSeq NP_216146.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)30S ribosomal protein S1
MTBC0 PGAP re-annotation30S ribosomal protein S1
Revised (this work)30S ribosomal protein S1. Pfam: S1 (PF00575.30), S1_RRP5 (PF23459.2).
Functional category (TubercuList)information pathways

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 77 publications

77 TB publications mention this gene. 77 publications discuss this gene. Queried separately, 73 records carry a M. tuberculosis context and 7 a non-TB mycobacterial context (species named in the 7-record verified sample: M. smegmatis (6), M. abscessus (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 77: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Transformer-accelerated discovery of inhibitors targeting the RpsAΔ438 deletion in PZA-resistant tuberculosis. doi:10.1186/s13321-026-01235-0 2026
Effects of mutations conferring pyrazinamide resistance among multidrug-resistant tuberculosis isolates from China. doi:10.1128/spectrum.00641-26 2026
Genome-wide detection of human 5' UTR variants that impact protein translation. doi:10.1016/j.ajhg.2026.02.020 2026
Comprehensive evaluation of the MeltPro MTB/PZA assay for prediction of pyrazinamide resistance in multidrug-resistant tuberculosis. doi:10.1128/spectrum.02745-24 2025
Detection of a Mixed-Strain Infection with Drug- and Multidrug-Resistant Mycobacterium avium Subspecies hominissuis in a Dog with Generalized Lymphadenomegaly. doi:10.3390/antibiotics14040416 2025
80 records returned by the alias sweep (a separate sweep from the 77 above; both are shown, neither is exhaustive)

Searched as: Rv1630, rpsA, Mb1656, ML1382, MMAR_2433, MSMEG_3833, MAB_2296 — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Transformer-accelerated discovery of inhibitors targeting the RpsA(Δ438) deletion in PZA-resistant tuberculosis. doi:10.1186/s13321-026-01235-0 names it J Cheminform 2026
Effects of mutations conferring pyrazinamide resistance among multidrug-resistant tuberculosis isolates from China. doi:10.1128/spectrum.00641-26 Microbiol Spectr 2026
Genome-wide detection of human 5' UTR variants that impact protein translation. doi:10.1016/j.ajhg.2026.02.020 Am J Hum Genet 2026
Comprehensive evaluation of the MeltPro MTB/PZA assay for prediction of pyrazinamide resistance in multidrug-resistant tuberculosis. doi:10.1128/spectrum.02745-24 Microbiol Spectr 2025
Detection of a Mixed-Strain Infection with Drug- and Multidrug-Resistant Mycobacterium avium Subspecies hominissuis in a Dog with Generalized Lymphadenomegaly. doi:10.3390/antibiotics14040416 Antibiotics (Basel) 2025
The epidemiology and gene mutation characteristics of pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates in Southern China. doi:10.1080/22221751.2024.2447607 Emerg Microbes Infect 2025
Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance-India, 2018-2020. doi:10.3389/fmicb.2024.1515627 Front Microbiol 2024
Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing. doi:10.1186/s12864-024-10909-8 BMC Genomics 2024
Genome sequencing analysis of the pncA, rpsA and panD genes responsible for pyrazinamide resistance of Mycobacterium tuberculosis from Indonesian isolates. doi:10.1111/tmi.14051 names it Trop Med Int Health 2024
Drug Susceptibility and Mutation Profiles in Mycobacterium tuberculosis Isolates from a Tertiary Care Hospital in Kerala, India. doi:10.4269/ajtmh.24-0042 Am J Trop Med Hyg 2024
Identification of novel single nucleotide variants in the drug resistance mechanism of Mycobacterium tuberculosis isolates by whole-genome analysis. doi:10.1186/s12864-024-10390-3 BMC Genomics 2024
In silico identification of phytochemical inhibitors for multidrug-resistant tuberculosis based on novel pharmacophore generation and molecular dynamics simulation studies. doi:10.1186/s13065-024-01182-7 BMC Chem 2024
A robust computational quest: Discovering potential hits to improve the treatment of pyrazinamide-resistant Mycobacterium tuberculosis. doi:10.1111/jcmm.18279 J Cell Mol Med 2024
Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Hunan, China. doi:10.2147/IDR.S436161 Infect Drug Resist 2024
Emerging insight of whole genome sequencing coupled with protein structure prediction into the pyrazinamide-resistance signature of Mycobacterium tuberculosis. doi:10.1016/j.ijantimicag.2023.107053 Int J Antimicrob Agents 2024
Association between fatty acid metabolism gene mutations and Mycobacterium tuberculosis transmission revealed by whole genome sequencing. doi:10.1186/s12866-023-03072-9 BMC Microbiol 2023
Selection of Multi-Drug Targets against Drug-Resistant Mycobacterium tuberculosis XDR1219 Using the Hyperbolic Mapping of the Protein Interaction Network. doi:10.3390/ijms241814050 Int J Mol Sci 2023
Genomic analysis of Mycobacterium tuberculosis variant bovis strains isolated from bovine in the state of Mato Grosso, Brazil. doi:10.3389/fvets.2022.1006090 Front Vet Sci 2022
Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update. doi:10.1007/s00284-022-03032-y Curr Microbiol 2022
[Investigation of pncA, rpsA and panD Gene Mutations Associated with Resistance in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates and Spoligotyping]. doi:10.5578/mb.20229801 names it Mikrobiyol Bul 2022
In Silico Drug Designing for ala438 Deleted Ribosomal Protein S1 (RpsA) on the Basis of the Active Compound Zrl15. doi:10.1021/acsomega.1c04764 names it ACS Omega 2022
Insights Into Mutations Induced Conformational Changes and Rearrangement of Fe(2+) Ion in pncA Gene of Mycobacterium tuberculosis to Decipher the Mechanism of Resistance to Pyrazinamide. doi:10.3389/fmolb.2021.633365 Front Mol Biosci 2021
The 7H11 Agar Medium Supplemented with Calf Bovine Serum for Susceptibility Testing of Mycobacterium tuberculosis Isolates Against Pyrazinamide. doi:10.1089/mdr.2020.0509 Microb Drug Resist 2021
Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacterium tuberculosis Isolates. doi:10.1128/AAC.02617-20 Antimicrob Agents Chemother 2021
Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis. doi:10.1128/AAC.01916-20 Antimicrob Agents Chemother 2021
Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China. doi:10.1371/journal.pntd.0009068 PLoS Negl Trop Dis 2021
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis. doi:10.1093/cid/ciaa1509 Clin Infect Dis 2021
Isolation, Molecular Typing, and Antibiotic Susceptibility Testing of Mycobacterium avium Subspecies hominissuis From a Dog With Generalized Mycobacteriosis. doi:10.3389/fvets.2020.569966 Front Vet Sci 2020
Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province. doi:10.2147/IDR.S260161 Infect Drug Resist 2020
Mycobacterium tuberculosis ribosomal protein S1 (RpsA) and variants with truncated C-terminal end show absence of interaction with pyrazinoic acid. doi:10.1038/s41598-020-65173-z names it Sci Rep 2020
Gibbs Free Energy Calculation of Mutation in PncA and RpsA Associated With Pyrazinamide Resistance. doi:10.3389/fmolb.2020.00052 names it Front Mol Biosci 2020
Discovery and evaluation of new compounds targeting ribosomal protein S1 in antibiotic-resistant Mycobacterium Tuberculosis. doi:10.1016/j.ejmech.2020.112317 Eur J Med Chem 2020
Mycobacterium smegmatis msmeg_3314 is involved in pyrazinamide and fluoroquinolones susceptibility via NAD(+)/NADH dysregulation. doi:10.2217/fmb-2019-0071 Future Microbiol 2020
Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China. doi:10.2147/IDR.S230774 Infect Drug Resist 2020
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB. doi:10.1186/s40001-019-0397-2 Eur J Med Res 2019
Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing. doi:10.1128/JCM.00145-19 J Clin Microbiol 2019
WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing. doi:10.1093/jac/dkz215 J Antimicrob Chemother 2019
Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance. doi:10.1038/s41598-019-44013-9 names it Sci Rep 2019
Introducing RpsA Point Mutations Δ438A and D123A into the Chromosome of Mycobacterium tuberculosis Confirms Their Role in Causing Resistance to Pyrazinamide. doi:10.1128/AAC.02681-18 names it Antimicrob Agents Chemother 2019
Exploring the Pyrazinamide Drug Resistance Mechanism of Clinical Mutants T370P and W403G in Ribosomal Protein S1 of Mycobacterium tuberculosis. doi:10.1021/acs.jcim.8b00956 J Chem Inf Model 2019
Insights into the Mechanisms of the Pyrazinamide Resistance of Three Pyrazinamidase Mutants N11K, P69T, and D126N. doi:10.1021/acs.jcim.8b00525 J Chem Inf Model 2019
Pyrazinamide drug resistance in RpsA mutant (∆438A) of Mycobacterium tuberculosis: Dynamics of essential motions and free-energy landscape analysis. doi:10.1002/jcb.28013 names it J Cell Biochem 2019
Lead compounds and key residues of ribosomal protein S1 in drug-resistant Mycobacterium tuberculosis. doi:10.1016/j.bioorg.2018.09.024 Bioorg Chem 2019
Insight into novel clinical mutants of RpsA-S324F, E325K, and G341R of Mycobacterium tuberculosis associated with pyrazinamide resistance. doi:10.1016/j.csbj.2018.09.004 names it Comput Struct Biotechnol J 2018
Codon-optimized DsRed fluorescent protein for use in Mycobacterium tuberculosis. doi:10.1186/s13104-018-3798-3 BMC Res Notes 2018
Pyrazinamide-resistant mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa and rpsA mutations. names it J Biol Regul Homeost Agents 2018
Identification of Mycobacterial Ribosomal Proteins as Targets for CD4(+) T Cells That Enhance Protective Immunity in Tuberculosis. doi:10.1128/IAI.00009-18 Infect Immun 2018
Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia. doi:10.1016/j.tube.2017.12.007 Tuberculosis (Edinb) 2018
Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China. doi:10.1016/j.cmi.2017.12.012 Clin Microbiol Infect 2018
Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China. doi:10.1186/s12879-017-2761-6 BMC Infect Dis 2017
Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids. doi:10.3390/molecules22091491 Molecules 2017
Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA. doi:10.1038/s41598-017-06415-5 names it Sci Rep 2017
A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis. doi:10.1038/s41598-017-03452-y names it Sci Rep 2017
Molecular mechanisms of action, resistance, detection to the first-line anti tuberculosis drugs: Rifampicin and pyrazinamide in the post whole genome sequencing era. doi:10.1016/j.tube.2017.04.008 Tuberculosis (Edinb) 2017
Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.00940-17 Antimicrob Agents Chemother 2017
Structural basis for ribosome protein S1 interaction with RNA in trans-translation of Mycobacterium tuberculosis. doi:10.1016/j.bbrc.2017.04.048 Biochem Biophys Res Commun 2017
Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That? doi:10.1128/JCM.02532-16 J Clin Microbiol 2017
Chemical shift assignments of Ribosomal protein S1 from Mycobacterium tuberculosis. doi:10.1007/s12104-017-9734-y Biomol NMR Assign 2017
Identification of Mycobacterial RplJ/L10 and RpsA/S1 Proteins as Novel Targets for CD4(+) T Cells. doi:10.1128/IAI.01023-16 names it Infect Immun 2017
Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations. doi:10.1016/j.diagmicrobio.2015.10.017 names it Diagn Microbiol Infect Dis 2016
Molecular characterization and drug susceptibility profile of a Mycobacterium avium subspecies avium isolate from a dog with disseminated infection. doi:10.1099/jmm.0.000221 J Med Microbiol 2016
Differential expression of putative drug resistance genes in Mycobacterium tuberculosis clinical isolates. doi:10.1093/femsle/fnv194 FEMS Microbiol Lett 2015
Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960. doi:10.1016/j.tube.2015.05.013 Tuberculosis (Edinb) 2015
Evaluation of the Ribosomal Protein S1 Gene (rpsA) as a Novel Biomarker for Mycobacterium Species Identification. doi:10.1155/2015/271728 names it Biomed Res Int 2015
Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China. doi:10.1128/AAC.04541-14 Antimicrob Agents Chemother 2015
Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan. doi:10.5588/ijtld.14.0305 names it Int J Tuberc Lung Dis 2015
Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide. doi:10.1111/mmi.12892 Mol Microbiol 2015
Mechanisms of Pyrazinamide Action and Resistance. doi:10.1128/microbiolspec.MGM2-0023-2013 Microbiol Spectr 2014
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis. doi:10.1038/emi.2014.61 Emerg Microbes Infect 2014
Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China. doi:10.1128/JCM.01903-13 names it J Clin Microbiol 2014
Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene. doi:10.1016/j.meegid.2013.06.008 Infect Genet Evol 2013
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis. doi:10.1038/emi.2013.38 Emerg Microbes Infect 2013
Comparison of gene expression profiles between pansensitive and multidrug-resistant strains of Mycobacterium tuberculosis. doi:10.1007/s00284-013-0376-8 Curr Microbiol 2013
[Quantitative proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis]. Wei Sheng Wu Xue Bao 2013
Mechanisms of Pyrazinamide Action and Resistance. doi:10.1128/microbiolspec.MGM2-0023-2013 Microbiol Spectr 2013
Reply to "role of rpsA gene sequencing in diagnosis of pyrazinamide resistance". doi:10.1128/JCM.02760-12 names it J Clin Microbiol 2013
Role of rpsA gene sequencing in diagnosis of pyrazinamide resistance. doi:10.1128/JCM.02739-12 names it J Clin Microbiol 2013
Gene sequencing for routine verification of pyrazinamide resistance in Mycobacterium tuberculosis: a role for pncA but not rpsA. doi:10.1128/JCM.00620-12 names it J Clin Microbiol 2012
Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. doi:10.1126/science.1208813 Science 2011
Sensitive detection of gene expression in mycobacteria under replicating and non-replicating conditions using optimized far-red reporters. doi:10.1371/journal.pone.0009823 PLoS One 2010

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

CRISPRi vulnerability

Vulnerability index -9.36 (95% CI -10.58 to -8.15). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionBinds mRNA; thus facilitating recognition of the initiation point. It is needed to translate mRNA with a short shine-dalgarno (SD) purine-rich sequence.

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb1656 · 99.8% identity
M. leprae ML1382 · 93.8% identity
M. marinum MMAR_2433 · 93.5% identity
M. smegmatis MSMEG_3833 · 92.9% identity
M. orygis RJtmp_001704 · 100.0% identity
M. abscessus MAB_2296 · 89.6% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WH43 SwissProt · reviewed · Evidence at protein level
UniProt nameSmall ribosomal subunit protein bS1
Curated functionBinds mRNA, facilitating recognition of most mRNAs by the 30S ribosomal subunit during translation initiation (By similarity). Probably plays a role in trans-translation; binds tmRNA (the product of the ssrA gene). In trans-translation Ala-aminoacylated transfer-messenger RNA (tmRNA, product of the ssrA gene; the 2 termini fold to resemble tRNA(Ala) while it encodes a short internal open reading frame (the tag peptide)) acts like a tRNA, entering the A-site of the ribosome and displacing the stalled mRNA (which is subsequently degraded). The ribosome then switches to translate the ORF on the t.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category J Translation, ribosomal structure and biogenesis
Preferred namerpsA
eggNOG descriptionRibosomal protein S1
Orthologous groupCOG0539
KEGG orthology K02945
KEGG pathways map03010
KEGG modules M00178
Gene Ontology (15) GO:0005575, GO:0005618, GO:0005622, GO:0005623, GO:0005737, GO:0005829, GO:0005886, GO:0008150, GO:0016020, GO:0030312, GO:0040007, GO:0044424 +3 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.723 · relaxed/neutral
Polymorphic sites (≥ 0.1% of strains) 3 synonymous, 7 missense, 0 nonsense, 1 frameshift
Disruption 1 distinct premature-stop/frameshift site(s); most common in 0.24% of strains (346) · clonal

Read the disruption percentage against its ceiling, not against 100%. The strain collection is deeply imbalanced by clade, so a loss fixed in an entire lineage still shows a small overall fraction: a gene disrupted in every L6 strain caps at 0.96% of the collection, in every M. caprae strain at 0.20%, in every M. microti strain at 0.02%. Of the 705 clades in this collection, 689 have a ceiling below 1%. A figure of "0.15% of strains" is therefore uninterpretable on its own — it can be noise or a complete, lineage-defining loss. Use the clade attribution row above, which gives the sub-clade sizes, and never read the percentage alone.

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

M. canettii dN/dS (deep-divergence selection) 0.31 (low power) · 4 consensus substitution(s)
low power (4 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 95.4% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 13/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 77.5%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 17 in the ORF — 17 in the essential state, 0 growth-defect, 0 non-essential, 0 growth-advantage. Saturation 0.000, mean read count 0. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 17 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Proteomics (mass spectrometry) detected

MS detectiondetected in 15 of 16 independent MS datasets
Integrated abundance1448.0 ppm · rank 146/3519 (95.9th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length481 aa
Molecular weight53.2 kDa
Theoretical pI4.83
GRAVY-0.351 (hydrophilic)
Aliphatic index92.6
Aromaticity0.06
Instability index42.2 (unstable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
S1PF00575.30 6.0e-27206–277 S1 RNA binding domain
S1_RRP5PF23459.2 2.2e-06206–276 RRP5 S1 domain

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 4nni (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 3 solved

PDBMethodResolutionCoverage
4nni X-ray diffraction 2.64 Å 32%
4nng X-ray diffraction 2.02 Å 31%
4nnk X-ray diffraction 2.31 Å 31%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (3 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 71.3

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
9gut-assembly1_B 1.00 0.45 0.35 0.33 44% 76% / 70% 6.1e-42 sig 9gut-assembly1_B 30S mRNA delivery complex (bS1 resolved)
9gux-assembly1_B 1.00 0.77 0.45 0.77 45% 54% / 100% 8.1e-28 sig 9gux-assembly1_B 30S-TEC (TEC in expressome position) Inactive state 1
9guv-assembly1_B 1.00 0.47 0.35 0.47 45% 72% / 99% 2.7e-36 sig 9guv-assembly1_B 30S mRNA delivery complex (closed-head)
8wi9-assembly1_b 1.00 0.86 0.29 0.86 89% 35% / 100% 5.7e-24 sig 8wi9-assembly1_b Cryo- EM structure of Mycobacterium smegmatis 30S ribosomal subunit (body 2) of 70S ribosome, bS1 and RafH.
7a05-assembly1_A 1.00 0.83 0.32 0.82 49% 35% / 98% 3.7e-22 sig 7a05-assembly1_A NMR structure of D3-D4 domains of Vibrio vulnificus ribosomal protein S1

Foldseek search of the AlphaFold DB model (mean pLDDT 71.3, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 2

Upstream (5' on genome)polA (+ strand, 162 bp gap)
Downstream (3' on genome)coaE (+ strand, 25 bp gap)
Predicted operon rpsA · coaE

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 2: rpsA · coaE — agrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT1666) exponential phase: operon of 3, Rv1629 · Rv1630 · Rv1631 (coverage 157.45)
expressed, no multi-gene operon (stationary phase, coverage 98.09) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Showing the 15 strongest of this gene's 255 partners at medium confidence (118 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 255 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv0718 rpsH exp (transferred) curated 30S ribosomal protein S8 999 1000 coexpression:968 experimental:928 database:816
Rv0702 rplD exp (transferred) curated 50S ribosomal protein L4 999 999 coexpression:962 experimental:920 database:599
Rv3459c rpsK exp (transferred) curated 30S ribosomal protein S11 999 999 coexpression:856 experimental:923 database:925
Rv0721 rpsE exp (transferred) curated 30S ribosomal protein S5 999 999 coexpression:936 experimental:888 database:925
Rv0682 rpsL exp (transferred) curated 30S ribosomal protein S12 999 998 coexpression:948 experimental:922 database:600 textmining:646
Rv3458c rpsD exp (transferred) curated 30S ribosomal protein S4 999 998 coexpression:875 experimental:922 database:844 textmining:452
Rv0683 rpsG exp (transferred) curated 30S ribosomal protein S7 998 998 coexpression:875 experimental:922 database:809 textmining:457
Rv0710 rpsQ exp (transferred) curated 30S ribosomal protein S17 998 997 coexpression:784 experimental:923 database:816 textmining:427
Rv0701 rplC exp (transferred) 50S ribosomal protein L3 997 996 coexpression:969 experimental:873 textmining:407
Rv0704 rplB exp (transferred) 50S ribosomal protein L2 997 996 coexpression:967 experimental:878 textmining:403
Rv0719 rplF exp (transferred) 50S ribosomal protein L6 996 995 coexpression:961 experimental:865
Rv0700 rpsJ exp (transferred) 30S ribosomal protein S10 995 995 coexpression:948 experimental:903
Rv2890c rpsB exp (transferred) curated 30S ribosomal protein S2 996 994 coexpression:854 experimental:915 database:540 textmining:498
Rv0715 rplX exp (transferred) 50S ribosomal protein L24 995 994 coexpression:951 experimental:879
Rv0716 rplE exp (transferred) 50S ribosomal protein L5 995 993 coexpression:943 experimental:882

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: 30S ribosomal protein S1
  • MTBC0 PGAP product: 30S ribosomal protein S1
  • Pfam (hmmscan --cut_ga): S1 PF00575.30 (E=6e-27), S1_RRP5 PF23459.2 (E=2e-06)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_216146.1)
  • Domains: Pfam-A via hmmscan --cut_ga — S1 (PF00575.30), S1_RRP5 (PF23459.2)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0539
  • Curated reference: UniProt P9WH43 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 71.3)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 255 functional partner(s)
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_001738|Rv1630|rpsA
MPSPTVTSPQVAVNDIGSSEDFLAAIDKTIKYFNDGDIVEGTIVKVDRDEVLLDIGYKTEGVIPARELSIKHDVDPNEVVSVGDEVEALVLTKEDKEGRLILSKKRAQYERAWGTIEALKEKDEAVKGTVIEVVKGGLILDIGLRGFLPASLVEMRRVRDLQPYIGKEIEAKIIELDKNRNNVVLSRRAWLEQTQSEVRSEFLNNLQKGTIRKGVVSSIVNFGAFVDLGGVDGLVHVSELSWKHIDHPSEVVQVGDEVTVEVLDVDMDRERVSLSLKATQEDPWRHFARTHAIGQIVPGKVTKLVPFGAFVRVEEGIEGLVHISELAERHVEVPDQVVAVGDDAMVKVIDIDLERRRISLSLKQANEDYTEEFDPAKYGMADSYDEQGNYIFPEGFDAETNEWLEGFEKQRAEWEARYAEAERRHKMHTAQMEKFAAAEAAGRGADDQSSASSAPSEKTAGGSLASDAQLAALREKLAGSA